Effect of Bile Acids on GLP-1 Secretion
NCT01666223
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Obesity
Interventions
DRUG:
Colesevelam
DRUG:
Chenodeoxycholic Acid
OTHER:
saline
DRUG:
Colesevelam 3750 mg + chenodeoxycholic acid 1250 mg
Sponsor
University Hospital, Gentofte, Copenhagen